billS3914Event Wednesday, February 25, 2026Analyzed

Supreme Court Ethics and Investigations Act

Neutral

Summary

Senator Booker introduced S3914, the Supreme Court Ethics and Investigations Act, on 2026-02-25. The bill was read twice and referred to the Senate Judiciary Committee. It has a companion bill in the House (HR7692) and a related ethics bill (HR9222). The bill authorizes no funding and is in early legislative stages, with no direct market impact.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.S3914 is a procedural ethics bill with no funding, no contracts, and no market impact.
  • 2.The bill is in early legislative stage with a companion in the House, but no committee action has occurred.
  • 3.No publicly traded companies are directly affected by this legislation.

Market Implications

No market implications. This bill does not affect any publicly traded company or sector. Investors should not adjust any positions based on this legislation.

Full Analysis

  1. What happened: Senator Cory Booker (D-NJ) introduced S3914, the Supreme Court Ethics and Investigations Act, on February 25, 2026. The bill was read twice and referred to the Senate Committee on the Judiciary. It is in the early legislative stage with no further action. The bill has 5 cosponsors and an identical companion bill in the House (HR7692). A related bill, HR9222 (Drain the Swamp Act), addresses broader government ethics.

  2. The money trail: This bill authorizes no funding. It is a legislative ethics bill that would establish a code of conduct and investigation mechanism for Supreme Court justices. There is no appropriation of funds, no tax credit, no grant program, and no procurement mechanism. The bill's impact is purely procedural and regulatory.

  3. Convergence: The identical companion bill in the House (HR7692) increases the probability of passage, but both are in early committee stages. The related Drain the Swamp Act (HR9222) shares an ethics/transparency theme but covers broader executive branch lobbying and financial disclosure. No direct market convergence exists.

  4. Structural winners and losers: This bill has no direct market impact. It does not authorize funding, create contracts, or regulate any industry. The affected sector is Law (judicial ethics), not a market sector. No publicly traded companies are directly affected.

  5. Timeline: The bill is in early stage — referred to committee. It requires committee markup, floor votes in both chambers, and presidential action. Given the 119th Congress runs through 2027, the bill has a long path ahead. No near-term market implications.

Key Legislators

Sen. Booker, Cory A. [D-NJ]

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →